Zoetis Inc. Share-based Payment Arrangement, Amount Capitalized
Zoetis Inc. (ZTS) reported Share-based Payment Arrangement, Amount Capitalized of $1.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement
us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount · last filed 2026-08-06
- Zoetis Inc. share-based payment arrangement, amount capitalized for the quarter ending 2026-06-30 was $1.00M, a 0.00% change year-over-year.
- Zoetis Inc. share-based payment arrangement, amount capitalized for the quarter ending 2026-03-31 was $1.00M, a 0.00% change year-over-year.
- Zoetis Inc. share-based payment arrangement, amount capitalized for the quarter ending 2025-12-31 was $0.00.
- Zoetis Inc. share-based payment arrangement, amount capitalized for the quarter ending 2025-09-30 was $1.00M, a 0.00% change year-over-year.
- Zoetis Inc. share-based payment arrangement, amount capitalized for fiscal 2025 was $1.00M, a 0.00% change from fiscal 2024.
- Zoetis Inc. share-based payment arrangement, amount capitalized for fiscal 2024 was $1.00M, a 0.00% change from fiscal 2023.
- Zoetis Inc. share-based payment arrangement, amount capitalized for fiscal 2023 was $1.00M, a 0.00% change from fiscal 2022.
- Zoetis Inc. share-based payment arrangement, amount capitalized for fiscal 2022 was $1.00M, a 0.00% change from fiscal 2021.
| Period end | Share-based Payment Arrangement, Amount Capitalized 3 month | Share-based Payment Arrangement, Amount Capitalized 6 month | Share-based Payment Arrangement, Amount Capitalized 9 month | Share-based Payment Arrangement, Amount Capitalized 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.00M 10-Q · filed 2026-08-06 | $2.00M derived: sum of 2 quarters · filed 2026-08-06 | $2.00M derived: sum of 3 quarters · filed 2026-08-06 | $3.00M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $1.00M 10-Q · filed 2026-05-07 | $1.00M derived: sum of 2 quarters · filed 2026-05-07 | $2.00M derived: sum of 3 quarters · filed 2026-05-07 | $3.00M derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $1.00M derived: sum of 2 quarters · filed 2026-02-12 | $2.00M derived: sum of 3 quarters · filed 2026-02-12 | $1.00M 10-K · filed 2026-02-12 |
| 2025-09-30 | $1.00M 10-Q · filed 2025-11-04 | $2.00M derived: sum of 2 quarters · filed 2025-11-04 | $1.00M 10-Q · filed 2025-11-04 | $3.00M derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-06-30 | $1.00M 10-Q · filed 2025-08-05 | $1.00M 10-Q · filed 2026-08-06 | $2.00M derived: sum of 3 quarters · filed 2026-05-07 | $3.00M derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-03-31 | $1.00M 10-Q · filed 2026-05-07 | $1.00M derived: sum of 2 quarters · filed 2026-05-07 | $2.00M derived: sum of 3 quarters · filed 2026-05-07 | $3.00M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $1.00M derived: sum of 2 quarters · filed 2026-02-12 | $2.00M derived: sum of 3 quarters · filed 2026-02-12 | $1.00M 10-K · filed 2026-02-12 |
| 2024-09-30 | $1.00M 10-Q · filed 2025-11-04 | $2.00M derived: sum of 2 quarters · filed 2025-11-04 | $1.00M 10-Q · filed 2025-11-04 | $3.00M derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-06-30 | $1.00M 10-Q · filed 2025-08-05 | $1.00M 10-Q · filed 2025-08-05 | $2.00M derived: sum of 3 quarters · filed 2026-02-12 | $3.00M derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-03-31 | $1.00M 10-Q · filed 2025-05-06 | $1.00M derived: sum of 2 quarters · filed 2026-02-12 | $2.00M derived: sum of 3 quarters · filed 2026-02-12 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $1.00M derived: sum of 2 quarters · filed 2026-02-12 | $1.00M 10-K · filed 2026-02-12 | |
| 2023-09-30 | $1.00M 10-Q · filed 2024-11-04 | $1.00M 10-Q · filed 2024-11-04 | ||
| 2022-12-31 | $1.00M 10-K · filed 2025-02-13 | |||
| 2021-12-31 | $1.00M 10-K · filed 2024-02-13 | |||
| 2020-12-31 | $1.00M 10-K · filed 2023-02-14 | |||
| 2019-12-31 | $1.00M 10-K · filed 2020-02-13 | |||
| 2018-12-31 | $1.00M 10-K · filed 2019-02-14 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $1.00M 10-K · filed 2019-02-14 | ||
| 2017-10-01 | $1.00M 10-Q · filed 2018-11-01 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $1.00M 10-K · filed 2018-02-15 | ||
| 2016-10-02 | $1.00M 10-Q · filed 2017-11-02 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | $1.00M derived: sum of 2 quarters · filed 2017-02-16 | $2.00M derived: sum of 3 quarters · filed 2017-02-16 | $1.00M 10-K · filed 2017-02-16 |
| 2015-09-27 | $1.00M 10-Q · filed 2016-11-03 | $2.00M derived: sum of 2 quarters · filed 2016-11-03 | $1.00M 10-Q · filed 2016-11-03 | |
| 2015-06-28 | $1.00M 10-Q · filed 2016-08-05 | $1.00M 10-Q · filed 2015-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |